Need Help?

Personalised therapy with MEK inhibition leads to a sustained complete response in an adolescent patient with a recurrent malignant peripheral nerve sheath tumor

Whole genome sequencing of tumour (90X) - normal (30X) patient pair and bulk transcriptome sequencing (80M PE reads) of tumour sample.

Request Access

Zero Childhood Cancer Data Access Policy

Please see URL for full policy

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00005214253 1620414288273 39.2 GB
EGAF00005214254 1620414288273 44.5 GB
EGAF00005214255 1620414288273 39.6 GB
EGAF00005214256 1620414288273 45.4 GB
EGAF00005214257 1620414288273 41.6 GB
EGAF00005214258 1624275251878 48.3 GB
EGAF00005214259 1620414288273 40.0 GB
EGAF00005214260 1620414288273 45.7 GB
EGAF00005214261 1620414288273 8.6 GB
EGAF00005214262 1620414288273 8.7 GB
10 Files (361.5 GB)